Xuedong Wei
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Ferroptosis and cancer prognosis
Papers in
-
- Prostate Cancer Diagnosis and Treatment 18
- Prostate Cancer Treatment and Research 8
- Ferroptosis and cancer prognosis 4
- Co-authors
- Jianquan Hou (23 shared papers)Yuhua Huang (29 shared papers)Guangbo Zhang (4 shared papers)Yuxin Lin (18 shared papers)Xueguang Zhang (2 shared papers)Zhixin Ling (4 shared papers)Chen Li (2 shared papers)Jinxian Pu (11 shared papers)
- Journals
- BMC Urology (4 papers)Frontiers in Oncology (4 papers)The Journal of Urology (3 papers)World Journal of Urology (3 papers)Journal of Translational Medicine (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xuedong Wei
72 papers receiving 990 citations
Peers
Comparison fields: 5 of 108
- Cancer Research 143
- Pulmonary and Respiratory Medicine 276
- Urology 48
- Immunology 139
- Oncology 145
Countries citing papers authored by Xuedong Wei
This map shows the geographic impact of Xuedong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuedong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuedong Wei more than expected).
Fields of papers citing papers by Xuedong Wei
This network shows the impact of papers produced by Xuedong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuedong Wei. The network helps show where Xuedong Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuedong Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 79 | |
| 2 | 2023 | 54 | |
| 3 | 2021 | 48 | |
| 4 | 2018 | 41 | |
| 5 | 2021 | 41 | |
| 6 | 2021 | 39 | |
| 7 | 2016 | 39 | |
| 8 | 2023 | 37 | |
| 9 | 2021 | 36 | |
| 10 | 2017 | 32 | |
| 11 | 2020 | 32 | |
| 12 | 2014 | 31 | |
| 13 | 2024 | 29 | |
| 14 | 2020 | 28 | |
| 15 | 2021 | 23 | |
| 16 | 2015 | 23 | |
| 17 | 2013 | 21 | |
| 18 | 2012 | 21 | |
| 19 | 2021 | 20 | |
| 20 | 2024 | 19 |
About Xuedong Wei
Xuedong Wei is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Surgery and Immunology, having authored 75 papers that have together received 998 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (8 papers), Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (4 papers), Cancer, Lipids, and Metabolism (4 papers), MicroRNA in disease regulation (4 papers), Urinary Bladder and Prostate Research (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Cancer Research (143 citations), Pulmonary and Respiratory Medicine (276 citations), Urology (48 citations), Immunology (139 citations) and Oncology (145 citations). Xuedong Wei has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Jianquan Hou, Yuhua Huang, Guangbo Zhang, Yuxin Lin, Xueguang Zhang, Zhixin Ling, Chen Li, Jinxian Pu, He Wang and Zhangxin He. Their work appears in journals such as BMC Urology, Frontiers in Oncology, The Journal of Urology, World Journal of Urology and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.